OnPoint Vision, Inc.

Developing intraocular lenses to correct residual refractive error after cataract surgery and treat age-related retinal pathologies

healthcare AI/medtech ophthalmology

Visit website

StageSeries B

Raised$11 million

Founded2019

Employees7

LocationAliso Viejo, CA

Business modelB2B, likely SaaS/product

About

Our mission is to provide a highly differentiated minimally-invasive surgical solution designed to customize the visual outcome of the pseudophakic eye. Primary product is the AccuraSee Intraocular Pseudophakic Contact Lens (IOPCL) invented by Kevin Cady, CEO and Founder of OnPoint Vision, Inc.

Product

Value proposition: Minimally-invasive surgical solution to customize visual outcomes for pseudophakic eyes and address vision decline from retinal diseases through AccuraSee intraocular lens technology
Target customers: ophthalmologists, eye care clinics, surgical centers
Regulatory: FDA interaction noted; regulatory pathway not fully specified

Founders

Kevin Cady — Founder and CEO

Products

AccuraSee Intraocular Pseudophakic Contact Lens (IOPCL)CadyLensintraocular lens implants

Key features

minimally-invasive surgical solutioncustomizes visual outcome of pseudophakic eyedesigned to fine-tune refractive errorvision recovery for retinal pathology

Technologies

intraocular lensespseudophakic contact lensesophthalmic implants

Target conditions

Residual refractive error after cataract surgeryage-related retinal pathologies (e.g., macular degeneration)visual decline post-cataract surgery

Care settings

clinicophthalmology practiceoperating roomhospital

Certifications

FDA (initial proposal accepted; later pathway discussion)

Competitors

other intraocular lens/IOPCL devices, refractive lens implants competitors

Investors

WP Global PartnersRefocus Group, Inc.

News

INTRAOCULAR PSEUDOPHAKIC CONTACT LENS WITH MECHANISM FOR SECURING BY ANTERIOR LEAFLET OF CAPSULAR WALL AND RELATED SYSTEM AND METHOD - Patent Application · 2025-10-16T05:00:00.000Z
OCULAR DRUG DELIVERY DEVICES SECURELY IMPLANTABLE INTO ANTERIOR SEGMENT OF EYE - Patent Application · 2025-07-03T05:00:00.000Z
OnPoint AR-AI Receives Award for Granted U.S. Patent Covering Augmented Reality (AR) Display for Spinal Rod Placement Related Applications | OnPoint AR-AI · 2025-01-30T18:28:44.000Z
Onpoint Ups the HealthTech Ante | Iris Medical Agent AI Platform · 2025-06-25T05:46:00.000Z
OnPoint to present its Augmented Reality AR-AI Technology Platform at the 2024 Wells Fargo Healthcare Conference · 2024-09-04T01:23:00.000Z
Onpoint Launches Practice Management as a Service (PMaaS™), Enhances Leadership Team - Onpoint Healthcare Partners Inc. · 2025-10-21T22:37:04.000Z

Browse similar startups

Related startups

Oral Genome — Carlsbad, CA
Orbits Oncology — San Francisco, CA
Pacific Pediatric Cardiology — Victorville, CA
Parakeet Health — San Francisco, CA
PathoGene, Inc. — Monrovia, CA
PATHOMIQ, Inc. — Cupertino, CA
Phenomix Sciences — Saint Paul, MN
PhyxUp Health — San Francisco, CA
Senphonix — Saint Paul, MN
SynchNeuro, Inc. — Chicago, IL
Vena Vitals — irvine, CA
Braveheart Bio — San Francisco, CA

Profile updated Jul 29, 2026. Sources: onpoint-vision.com